PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
8 hedge funds and large institutions have $245K invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
11% less funds holding
Funds holding: 9 → 8 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
69% less capital invested
Capital invested by funds: $784K → $245K (-$539K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
+$336K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$258 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$690K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
| 3 |
Mariner
Overland Park,
Kansas
|
-$2.93K |
| 4 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$2.93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JFG
1
Jefferies Financial Group
New York
| $189K | +$336K | +57,270 | New |
|
|
VPIM
2
Vanguard Personalized Indexing Management
Oakland,
California
| $18.1K | -$2.93K | -500 | -8% |
|
|
3
Mariner
Overland Park,
Kansas
| $18K | -$2.93K | -500 | -8% |
|
|
4
Citadel Advisors
Miami,
Florida
| $12.4K | +$11.4K | +1,941 | +107% |
|
5
Group One Trading
Chicago,
Illinois
| $3.5K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $1.57K | +$258 | +44 | +10% |
|
|
IC
7
Ikarian Capital
Dallas,
Texas
| $1.19K | – | – | – |
|
|
ADL
8
Asset Dedication LLC
San Francisco,
California
| $1K | – | – | – |
|
|
BI
9
BVF Inc
San Francisco,
California
| – | -$690K | -131,466 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$6K | -1,101 | Closed |
|
PHXM Hedge Fund Activity: Q4 2022 in Review
8 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q4 2022, worth a combined $245K — down 69% from $784K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHXM and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $336K. The largest seller was BVF Inc, exiting entirely with an estimated $690K sold.
- 8 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q4 2022, down from 9 in Q3 2022.
- Funds reported $245K of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q4 2022, down 69% quarter-over-quarter.
- 1 fund opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares buyer in Q4 2022 was Jefferies Financial Group, an estimated $336K added.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q4 2022 was BVF Inc, an estimated $690K sold.
Based on aggregated 13F filings for Q4 2022.